Rodabe Amaria is an Oncologist and a Hematologist in Houston, Texas. Dr. Amaria is rated as an Elite provider by MediFind in the treatment of Melanoma. Her top areas of expertise are Melanoma, Primitive Neuroectodermal Tumor (PNET), Posterior Fossa Tumor, and Metastatic Brain Tumor.

Jennifer Mcquade is an Oncologist in Houston, Texas. Dr. Mcquade has been practicing medicine for over 17 years and is rated as an Elite provider by MediFind in the treatment of Melanoma. Her top areas of expertise are Melanoma, Sinus Cancer, Teratocarcinosarcoma, and Olfactory Neuroblastoma.

Anthony Olszanski is an Oncologist and a Transplant Surgeon in Philadelphia, Pennsylvania. Dr. Olszanski is rated as an Elite provider by MediFind in the treatment of Melanoma. His top areas of expertise are Melanoma, Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), and ALK-Positive Non-Small Cell Lung Cancer.

Joseph Clark is a Hematologist Oncology specialist and a Hematologist in Maywood, Illinois. Dr. Clark is rated as an Elite provider by MediFind in the treatment of Melanoma. His top areas of expertise are Melanoma, Renal Cell Carcinoma (RCC), Nasopharyngeal Carcinoma, Bone Marrow Aspiration, and Gastrostomy. Dr. Clark is currently accepting new patients.

Sekwon Jang is a Hematologist Oncology specialist and an Oncologist in Falls Church, Virginia. Dr. Jang is rated as an Elite provider by MediFind in the treatment of Melanoma. His top areas of expertise are Melanoma, Merkel Cell Carcinoma, Cutaneous T-Cell Lymphoma (CTCL), and Squamous Cell Skin Carcinoma. Dr. Jang is currently accepting new patients.

Richard Carvajal is an Oncologist in Lake Success, New York. Dr. Carvajal is rated as an Elite provider by MediFind in the treatment of Melanoma. His top areas of expertise are Metastatic Uveal Melanoma, Uveal Melanoma, Melanoma of the Eye, Melanoma, and Tissue Biopsy.

Diwakar Davar is a Hematologist and an Oncologist in Pittsburgh, Pennsylvania. Dr. Davar is rated as an Elite provider by MediFind in the treatment of Melanoma. His top areas of expertise are Melanoma, Merkel Cell Carcinoma, Metastatic Uveal Melanoma, Uveal Melanoma, and Gamma Knife Radiosurgery.

Kim Margolin is an Oncologist in Santa Monica, California. Dr. Margolin is rated as an Elite provider by MediFind in the treatment of Melanoma. Her top areas of expertise are Melanoma, Merkel Cell Carcinoma, Testicular Cancer, and Metastatic Brain Tumor. Dr. Margolin is currently accepting new patients.

Lynn Schuchter is an Oncologist in Philadelphia, Pennsylvania. Dr. Schuchter is rated as an Elite provider by MediFind in the treatment of Melanoma. Her top areas of expertise are Melanoma, Melanoma of the Eye, Squamous Cell Skin Carcinoma, and Merkel Cell Carcinoma. Dr. Schuchter is currently accepting new patients.

Mark Faries is an Oncologist and a Surgical Oncologist in Los Angeles, California. Dr. Faries is rated as an Elite provider by MediFind in the treatment of Melanoma. His top areas of expertise are Melanoma, Merkel Cell Carcinoma, Head and Neck Squamous Cell Carcinoma (HNSCC), Squamous Cell Skin Carcinoma, and Lymphadenectomy. Dr. Faries is currently accepting new patients.

Brendan Curti is an Oncologist in Portland, Oregon. Dr. Curti is rated as an Elite provider by MediFind in the treatment of Melanoma. His top areas of expertise are Melanoma, Renal Cell Carcinoma (RCC), Prostate Cancer, and Chromophobe Renal Cell Carcinoma.

John M. Kirkwood, MD, is a professor of medicine, dermatology, and clinical and translational science at the University of Pittsburgh School of Medicine and the Clinical and Translational Science Institute at the University of Pittsburgh. Dr. Kirkwood directs the Melanoma Center at UPMC Hillman Cancer Center and specializes in melanoma research and the prevention and early detection of melanoma, as well as the treatment of advanced disease and adjuvant therapy of resectable disease. Dr. Kirkwood is rated as an Elite provider by MediFind in the treatment of Melanoma. His top areas of expertise are Melanoma, Melanoma of the Eye, Metastatic Uveal Melanoma, and Uveal Melanoma.

Dr. Lipson is an internationally-recognized skin cancer and immunotherapy specialist at Johns Hopkins. He received his medical degree in 2005 from the Mount Sinai School of Medicine in New York City, where he graduated with distinction in research. He completed his internship and residency in Internal Medicine at The Johns Hopkins Hospital, and completed a Medical Oncology fellowship at the Johns Hopkins Kimmel Cancer Center. Dr. Lipson leads cutting edge clinical trials for patients with melanoma and other skin cancers. As a member of the Johns Hopkins Melanoma and Cancer Immunology Programs, he focuses on evaluating novel therapies for patients with high-risk or advanced disease. Dr. Lipson’s publications include the first reports of organ transplant recipients treated with immune checkpoint inhibitors for advanced cancer, and the first description of kidney retransplantation performed after immunotherapy–related organ rejection. Based on his published work, Dr. Lipson initiated a clinical trial testing a novel combination of immune-based therapies for kidney transplant recipients with advanced selected cancers. Results from this trial - the first of its kind - were reported in 2022 at an international oncology meeting. Dr. Lipson is a leader in the clinical development of relatlimab, an antibody blocking the LAG-3 immune checkpoint. He leads a phase 2 trial testing combination immune checkpoint inhibitor therapy—including anti-LAG-3—for patients with advanced basal cell carcinoma. In June 2021, Dr. Lipson presented findings from the first phase 3 study establishing the LAG-3 pathway as the third immune checkpoint pathway in history, after CTLA-4 and PD-1, for which blockade has clinical benefit. This trial supported the FDA's approval of a new therapy for patients with advanced melanoma. In addition to his research activities, Dr. Lipson is an educator in the field of cancer immunotherapy. Many of his lectures focus on the management of immune-mediated drug toxicities associated with novel cancer drugs. Dr. Lipson conducts regular clinical practices in Baltimore, Maryland and at Sibley Memorial Hospital in Washington, D.C. as part of the multidisciplinary Melanoma Program at Johns Hopkins. Dr. Lipson is rated as an Elite provider by MediFind in the treatment of Melanoma. His top areas of expertise are Melanoma, Merkel Cell Carcinoma, Melanoma of the Eye, Metastatic Uveal Melanoma, and Pancreaticoduodenectomy.

Ravi Amaravadi is an Oncologist in Philadelphia, Pennsylvania. Dr. Amaravadi is rated as an Elite provider by MediFind in the treatment of Melanoma. His top areas of expertise are Melanoma, Merkel Cell Carcinoma, Colorectal Cancer, Tissue Biopsy, and Liver Embolization. Dr. Amaravadi is currently accepting new patients.

David Lawson is an Oncologist in Atlanta, Georgia. Dr. Lawson has been practicing medicine for over 52 years and is rated as an Elite provider by MediFind in the treatment of Melanoma. His top areas of expertise are Melanoma, Metastatic Brain Tumor, Melanoma of the Eye, and Posterior Fossa Tumor.

Dr. William H. Sharfman is an associate professor of oncology and dermatology at the Johns Hopkins University School of Medicine. His areas of clinical expertise include cutaneous oncology, dermatology and immunotherapy. He helped create the well-established Melanoma Program at the Johns Hopkins Kimmel Cancer Center in 1994. Dr. Sharfman serves as the director of cutaneous oncology and clinical co-director for oncology at the Johns Hopkins Melanoma Program. He earned his M.D. from the University of Toledo College of Medicine. He completed his residency at Cleveland Clinic and performed a fellowship in hematology and oncology at Cleveland Clinic. Dr. Sharfman's research interests include novel therapies for high risk and advanced melanoma patients. Dr. Sharfman is rated as an Elite provider by MediFind in the treatment of Melanoma. His top areas of expertise are Melanoma, Merkel Cell Carcinoma, Eccrine Porocarcinoma, and Familial Pancreatic Cancer.

Yana Najjar is a Hematologist Oncology provider in Pittsburgh, Pennsylvania. Dr. Najjar is rated as an Elite provider by MediFind in the treatment of Melanoma. Her top areas of expertise are Melanoma, Melanoma of the Eye, Metastatic Uveal Melanoma, Renal Cell Carcinoma (RCC), and Gamma Knife Radiosurgery. She is board certified in American Board Of Internal Medicine. Dr. Najjar is currently accepting new patients.

Asim Amin is an Oncologist in Charlotte, North Carolina. Dr. Amin is rated as an Elite provider by MediFind in the treatment of Melanoma. His top areas of expertise are Renal Cell Carcinoma (RCC), Melanoma, Chromophobe Renal Cell Carcinoma, and Clear Cell Sarcoma. Dr. Amin is currently accepting new patients.

Brent Hanks is an Oncologist in Durham, North Carolina. Dr. Hanks is rated as an Elite provider by MediFind in the treatment of Melanoma. His top areas of expertise are Melanoma, Merkel Cell Carcinoma, Melanoma of the Eye, and Metastatic Uveal Melanoma. Dr. Hanks is currently accepting new patients.

Melinda Yushak is an Oncologist in Atlanta, Georgia. Dr. Yushak has been practicing medicine for over 17 years and is rated as an Elite provider by MediFind in the treatment of Melanoma. Her top areas of expertise are Melanoma, Merkel Cell Carcinoma, Undifferentiated Pleomorphic Sarcoma, and Mesenchymoma.